FDA Initiates Safety Review of Mifepristone Abortion Medication
The Food and Drug Administration has begun a retrospective safety study concerning the abortion pill mifepristone. This extensive review will analyze numerous cases, with initial findings anticipated in July. The medication received FDA approval in 2000 for use in early pregnancies.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.